Viviane Quirke
Biographic Data
| ID | 5236191 |
|---|---|
| NAME | Viviane Quirke |
| GIVEN NAMES | Viviane |
| FAMILY NAME | Quirke |
| SIGNATURE | QUIRKE V |
| AFFILIATIONS | Oxford Brookes University |
| VERIFIED | No |
| TOTAL WORKS | 9 |
| TOTAL CITATIONS | 2 |
| AUTHOR COUNT | 9 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1998 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 1 |
Horizontal Chemistry
In 1976 Raymond Williams commented, ‘Culture is one of the two or three most complicated words in the English language.’ Such implied difficulty has not prevented Bloomsbury Academic, since the 2000s, from publishing around forty series of their well-produced and generously illustrated Cultural Histories, with, according to their website, a further fifty in progress. Each series contains six volumes, each book covering, in theory, the same chrono…
Targeting the American Market for Medicines, ca. 1950s–1970s: ICI and Rhône-Poulenc Compared
The forces that have shaped American medicine include a wide set of interrelated changes, among them the changing research, development, and marketing practices of the pharmaceutical industry. This article compares the research and development (R&D) and marketing strategies of the British group Imperial Chemical Industries (ICI, whose Pharmaceutical Division was spun off and merged with the Swedish company Astra to form AstraZeneca) and its Frenc…
Entries
Penicillin: Triumph and Tragedy (review)
Making British Cortisone: Glaxo and the development of Corticosteroids in Britain in the 1950s–1960s
French biomedicine in the mirror of America
War and Change in the Pharmaceutical Industry: A Comparative Study of Britain and France in the Twentieth Century
Pourquoi et comment la Seconde Guerre Mondiale a-t-elle influencé les destinées de l’industrie pharmaceutique au XX e siècle ? Est-elle la cause du « succès » des firmes britanniques et du « recul » des laboratoires français ? Cet article apporte quelques réponses à partir de deux exemples, la division pharmaceutique d’ICI, façonnée par la guerre, et Rhône-Poulenc, qui conserve sa capacité d’innovation malgré les difficultés de l’Occupation
Wealth of Contrasts: Nyegaard & Co.-A Norwegian Pharmaceutical Company, 1874-1985 by Rolv Petter Amdam and Knut Sogner
350 Book Reviews TECHNOLOGY AND CULTURE up, Adler provides an intelligent and cogently argued study of the industrial interest-group politics. Unfortunately, that framework is no longer adequate. As a close reading ofits footnotes attests, Adler’s book rests largely on older secondary sources in Italian and English, supplemented by relatively little original archival research. The real difficulties lie, however, in his apparent failure to consult…
Wealth of Contrasts: Nyegaard & Co.-A Norwegian Pharmaceutical Company, 1874-1985
French biomedicine in the mirror of America
War and Change in the Pharmaceutical Industry: A Comparative Study of Britain and France in the Twentieth Century
Pourquoi et comment la Seconde Guerre Mondiale a-t-elle influencé les destinées de l’industrie pharmaceutique au XX e siècle ? Est-elle la cause du « succès » des firmes britanniques et du « recul » des laboratoires français ? Cet article apporte quelques réponses à partir de deux exemples, la division pharmaceutique d’ICI, façonnée par la guerre, et Rhône-Poulenc, qui conserve sa capacité d’innovation malgré les difficultés de l’Occupation
Wealth of Contrasts: Nyegaard & Co.-A Norwegian Pharmaceutical Company, 1874-1985 by Rolv Petter Amdam and Knut Sogner
350 Book Reviews TECHNOLOGY AND CULTURE up, Adler provides an intelligent and cogently argued study of the industrial interest-group politics. Unfortunately, that framework is no longer adequate. As a close reading ofits footnotes attests, Adler’s book rests largely on older secondary sources in Italian and English, supplemented by relatively little original archival research. The real difficulties lie, however, in his apparent failure to consult…
Wealth of Contrasts: Nyegaard & Co.-A Norwegian Pharmaceutical Company, 1874-1985
French biomedicine in the mirror of America
War and Change in the Pharmaceutical Industry: A Comparative Study of Britain and France in the Twentieth Century
Pourquoi et comment la Seconde Guerre Mondiale a-t-elle influencé les destinées de l’industrie pharmaceutique au XX e siècle ? Est-elle la cause du « succès » des firmes britanniques et du « recul » des laboratoires français ? Cet article apporte quelques réponses à partir de deux exemples, la division pharmaceutique d’ICI, façonnée par la guerre, et Rhône-Poulenc, qui conserve sa capacité d’innovation malgré les difficultés de l’Occupation
Making British Cortisone: Glaxo and the development of Corticosteroids in Britain in the 1950s–1960s
Penicillin: Triumph and Tragedy (review)
Entries
Targeting the American Market for Medicines, ca. 1950s–1970s: ICI and Rhône-Poulenc Compared
The forces that have shaped American medicine include a wide set of interrelated changes, among them the changing research, development, and marketing practices of the pharmaceutical industry. This article compares the research and development (R&D) and marketing strategies of the British group Imperial Chemical Industries (ICI, whose Pharmaceutical Division was spun off and merged with the Swedish company Astra to form AstraZeneca) and its Frenc…
Horizontal Chemistry
In 1976 Raymond Williams commented, ‘Culture is one of the two or three most complicated words in the English language.’ Such implied difficulty has not prevented Bloomsbury Academic, since the 2000s, from publishing around forty series of their well-produced and generously illustrated Cultural Histories, with, according to their website, a further fifty in progress. Each series contains six volumes, each book covering, in theory, the same chrono…
Historical Medical Research and Treatments (4 works) · History (4 works) · Art (3 works) · Business (3 works) · History (3 works) · History of Science and Medicine (3 works) · Philosophy (3 works) · Political science (3 works) · Classics (2 works) · Computer Science (2 works)